2017-07-28 |
36 |
|
INC.. (Attachments: # 1 Exhibit 1 - U.S. Patent No. 7,772,209, # 2 Exhibit 2- File History of U.S. Pat…, # 22 Exhibit 20 - U.S. Patent No. 5,344,932, # 23 Exhibit 21 - U.S. Patent No. 6,686,365, # 24 Exhibit…Exhibit 6 - Judgment of the High Court of Justice (Patents Court), United Kingdom, 2014 EWHC 1511 (Pat) (May…(May 15, 2014), # 8 Exhibit 7 - Judgment (Patents Court), United Kingdom, 2015 EWHC 555 (Pat) (June 25…Exhibit 8 (Pt 1) - Approved Redacted Judgment (Patents Court), 2016 EWHC 234 (Pat), United Kingdom (Feb |
External link to document |
2017-09-22 |
49 |
|
Exhibit Index of Exhibits, # 2 Exhibit 1-U.S. Patent No. 7,772,209, # 3 Exhibit 2-File History of U.S. Pat.…1987), # 23 Exhibit 20-U.S. Patent No. 5,344,932, # 24 Exhibit 21-U.S. Patent No. 6,686,365, # 25 Exhibit…Exhibit 6-Judgment of the High Court of Justice (Patents Court), United Kingdom, 2014 EWHC 1511 (Pat) (May…(May 15, 2014), # 9 Exhibit 7-Judgment (Patents Court), United Kingdom, 2015 EWHC 555 (Pat) (June 25, …Exhibit 8 (Pt 1) _ Approved Redacted Judgment (Patents Court), 2016 EWHC 234 (Pat), United Kingdom (Feb |
External link to document |
2018-04-06 |
76 |
|
# 1 List of Exhibits, # 2 Exhibit 1-U.S. Patent No. 7,772,209, # 3 Exhibit 2-File History of U.S. Pat.…1987), # 23 Exhibit 20-U.S. Patent No. 5,344,932, # 24 Exhibit 21-U.S. Patent No. 6,686,365, # 25 Exhibit…Exhibit 6-Judgment of the High Court of Justice (Patents Court), United Kingdom, 2014 EWHC 1511 (Pat) (May…(May 15, 2014), # 9 Exhibit 7-Judgment (Patents Court), United Kingdom, 2015 EWHC 555 (Pat) (June 25, …Exhibit 8 (Pt 1) - Approved Redacted Judgment (Patents Court), 2016 EWHC 234 (Pat), United Kingdom (Feb |
External link to document |
2018-06-15 |
89 |
Order on Motion for Summary Judgment |
for infringement of Lilly's U.S. Patent 7,772,209 ("the '209 Patent"). On April 6, 2018, Hospira filed… for infringement of Lilly’s U.S. Patent 7,772,209 (“the ’209 Patent”). On April 6,
2018, Hospira filed…infringe the patent in suit and the doctrine of equivalents does not expand the scope of Lilly's patent to include… the patent in suit and the doctrine of equivalents does not expand the scope
of Lilly’s patent to include… During prosecution of its patent application for ALIMTA®, the U.S. Patent and Trademark
Office originally |
External link to document |